KDM4A and neoplasm: In line with these observations, evidence has emerged that the JMJD2/KDM4 subfamily of demethylases is highly expressed in several tumor types and, specifically, JMJD2B expression levels appears to be increased in breast, colorectal, gastric, prostate, lung and bladder malignancies (13–18,43–45).